EUVIMEDEUVIMED entdecken
Crossref

Toosendanin promotes prostate cancer cell apoptosis, ferroptosis and M1 polarization via USP39-mediated PLK1 deubiquitination

Siyao Shen, Guifeng Xue, Zhigang Zeng, Liang Peng, Weidong Nie, Xiaochun Zeng

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-03916-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Siyao Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, No.90, Bayi Avenue, Xihu District, Nanchang City, 330003…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins, Prostatic Neoplasms, Protein Serine-Threonine Kinases, Ferroptosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toosendanin (TSN) can inhibit the malignant process of many cancers, and has the potential to be developed as an anti-tumor drug. However, the role and mechanism of TSN in prostate cancer (PCa) progression remain unclear. PCa cells (DU145 and LNCaP) were treated with TSN. Cell viability was detected by cell counting kit 8 assay. Cell proliferation, apoptosis and metastasis were assessed by colony formation assay, flow cytometry and transwell assay. Cell ferroptosis was evaluated by examining Fe2+, MDA and lipid-ROS levels. M1 polarization markers were analyzed by flow cytometry. Immunohistochemical staining, quantitative real-time PCR and western blot were used to detect ubiquitin-specific protease 39 (USP39) and polo-like kinase 1 (PLK1) expression. Cycloheximide treatment, Co-IP assay and ubiquitination assay were performed to confirm the regulation of USP39 on PLK1. In vivo experiments were employed to determine the effect of TSN and USP39 on PCa tumor growth. TSN treatment suppressed PCa cell proliferation, cell cycle, migration, and invasion, while enhanced apoptosis, ferroptosis, and M1 polarization. USP39 was upregulated in PCa tissues and cells, and its protein expression was reduced by TSN. USP39 overexpression reversed the regulation of TSN on PCa cell functions. PLK1 had elevated expression in PCa, and USP39 stabilized its protein expression by deubiquitination. USP39 knockdown inhibited PCa cell behaviors, and its regulation was abolished by PLK1 overexpression. Meanwhile, TSN reduced PCa tumor growth by regulating USP39/PLK1. TSN played anti-tumor role in PCa, which promoted PCa cell apoptosis, ferroptosis, and M1 polarization by inhibiting USP39/PLK1 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene ProteinsProstatic NeoplasmsProtein Serine-Threonine KinasesFerroptosisCell Cycle ProteinsUbiquitin-Specific ProteasesAntineoplastic AgentsMalePolo-Like Kinase 1HumansApoptosisCell Line, TumorAnimalsUbiquitinationMice, NudeMiceCell ProliferationMice, Inbred BALB C

Stichwörter der Autor:innen

PLK1Prostate cancerToosendaninUSP39

Substanzen

Proto-Oncogene ProteinsPolo-Like Kinase 1Protein Serine-Threonine KinasesCell Cycle ProteinsUbiquitin-Specific ProteasesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Urology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, No.90, Bayi Avenue, Xihu District, Nanchang City, 330003, Jiangxi Province, China.
  • Department of Urology, The Fourth Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang City, 330003, Jiangxi Province, China.
  • Institute of Urology, Jiangxi University of Traditional Chinese Medicine, Nanchang City, 330003, Jiangxi Province, China.
  • Department of Urology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, No.90, Bayi Avenue, Xihu District, Nanchang City, 330003, Jiangxi Province, China. xiaochunz1969@163.com.
  • Department of Urology, The Fourth Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang City, 330003, Jiangxi Province, China. xiaochunz1969@163.com.
  • Institute of Urology, Jiangxi University of Traditional Chinese Medicine, Nanchang City, 330003, Jiangxi Province, China. xiaochunz1969@163.com.

Zitieren

APA

Shen, S., Xue, G., Zeng, Z., Peng, L., Nie, W., & Zeng, X. (2025). Toosendanin promotes prostate cancer cell apoptosis, ferroptosis and M1 polarization via USP39-mediated PLK1 deubiquitination. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-03916-3

Vancouver

Shen S, Xue G, Zeng Z, Peng L, Nie W, Zeng X. Toosendanin promotes prostate cancer cell apoptosis, ferroptosis and M1 polarization via USP39-mediated PLK1 deubiquitination. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-03916-3

BibTeX
@article{Shen2025,
  author = {Shen, Siyao and Xue, Guifeng and Zeng, Zhigang and Peng, Liang and Nie, Weidong and Zeng, Xiaochun},
  title = {Toosendanin promotes prostate cancer cell apoptosis, ferroptosis and M1 polarization via USP39-mediated PLK1 deubiquitination},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-03916-3}
}
Kostenlos starten →